Save time and get answers to complex questions with AI chat
Stribild expiry date?How much is mebendazole?Dabrafenib patent expiration?Lipitor vs generics what's the price gap?Mobic injection patent oehringer ingelheim france?
See the DrugPatentWatch profile for qulipta
Qulipta (atogepant) is a medication used for the preventive treatment of migraine [1]. It is a calcitonin gene-related peptide (CGRP) receptor antagonist [1].
The availability of a generic version of Qulipta is tied to patent expirations. DrugPatentWatch.com monitors these patents and provides information on when generic entry might occur [2]. As of current information, specific dates for generic Qulipta availability are not publicly established due to ongoing patent protection [2].
Qulipta is manufactured by AbbVie [1].
Qulipta works by blocking the action of a molecule called CGRP, which is believed to play a role in migraine headaches [1]. By inhibiting CGRP, the medication helps to prevent migraines from occurring [1].
Common side effects reported with Qulipta include upper respiratory tract infection, nausea, diarrhea, and fatigue [1]. Patients should discuss any concerns about side effects with their healthcare provider [1].
Other Questions About Qulipta :